BioCentury
ARTICLE | Company News

Pharmacyclics, Hoechst Celanese Corp. deal

September 16, 1996 7:00 AM UTC

Hoechst's Fine Chemical business unit will manufacture and supply PCYC's texaphyrin products, which initially include Lu-Tex for photodynamic therapy of cancer and atherosclerosis and Gd-Tex for radiation sensitization in cancer treatment.

Hoechst Celanese receives exclusive worldwide rights to supply the bulk drug substance contained in the products. ...